 ATLANTA, Jan. 4, 2021 PRNewswire -- Inhibikase Therapeutics, Inc. Nasdaq: IKT Inhibikase, a clinical-stage pharmaceutical company developing therapeutics for Parkinsons disease and related disorders, announced today that it has formed a partnership with Clintrex Research... 